WW · Ww International, Inc.
Market Cap
$172.23M
Shares
10.00M
WW metrics
51 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$17.09
Market cap
$172.23M
Price action
19 metricsPrice change (1W)
-7.8%
Price change (30D)
+1.2%
Price change (3M)
+1.8%
Price change (6M)
-25.3%
Price change (YTD)
-44.3%
Price change (1Y)
-49.0%
Trailing year
Price change (5Y)
—
52-week high
$34.92
52-week low
$9.12
Change from 52-week high
-53.4%
Change from 52-week low
+78.4%
Annualized volatility
91.4%
Beta
2.4
RSI (14D)
53.6
Price vs SMA 50
+5.4%
Price vs SMA 200
-12.8%
Avg volume (3M)
188,301
Relative volume
0.8
Average dollar volume
$3.07M
Company
3 metricsSector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
10.00M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.2×
reciprocal yield 457.0%
P / book
0.6
reciprocal yield 171.9%
FCF yield
—
TTM · current market cap
Buyback yield
0.0%
P / FCF
—
P / operating cash flow
—
Earnings yield
—
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-05
Profitability
9 metricsGross margin
67.8%
Operating margin
-30.1%
Trailing 12 months
Net margin
-44.0%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+1,234.1%
Year over year
Net income growth YoY
+1,022.3%
Revenue (TTM)
$740.87M
Trailing 12 months
EPS growth YoY
+984.6%
Shares change YoY
+0.0%
Year over year · more shares
Revenue CAGR (3Y)
-13.4%
Revenue CAGR (5Y)
-11.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
332.0%
Return on assets
111.5%
Debt / equity
—
Current ratio
1.4
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$101.50M
Total assets
$840.44M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
3 metrics13F filers
78
13F filer change QoQ
-6
Institutional ownership
75.3%
Short interest
3 metricsShort interest
16.6%
Latest settlement · 6.3 days to cover
Days to cover
6.3d
Short-squeeze score
76 / 100
Insider activity
2 metricsNet insider buying (90D)
$100,132
Insider-sentiment score
81 / 100
Risk flags
1 metricsGoing concern
—
Key facts
CIK
105319
CUSIP
98262P200
13F (30d)
65 filings
63 filers
Visit website
Investor relations